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Abstract
Autophagy is involved in cellular homeostasis and maintenance and may play a role in cardi-
ometabolic health. We aimed to elucidate the role of autophagy in cardiometabolic traits by
investigating genetic variants and DNA methylation in autophagy-related genes in relation
to cardiovascular diseases and related traits. To address this research question, we imple-
mented a multidirectional approach using several molecular epidemiology tools, including
genetic association analysis with genome wide association studies data and exome
sequencing data and differential DNA methylation analysis. We investigated the 21 autop-
hagy-related genes in relation to coronary artery disease and a number of cardiometabolic
traits (blood lipids, blood pressure, glycemic traits, type 2 diabetes). We used data from the
largest genome wide association studies as well as DNA methylation and exome sequenc-
ing data from the Rotterdam Study. Single-nucleotide polymorphism rs110389913 in
AMBRA1 (p-value = 4.9×10−18) was associated with blood proinsulin levels, whereas
rs6587988 in ATG4C and rs10439163 in ATG4D with lipid traits (ATG4C: p-value =
2.5×10−15 for total cholesterol and p-value = 3.1×10−18 for triglycerides, ATG4D: p-value =
9.9×10−12 for LDL and p-value = 1.3×10−10 for total cholesterol). Moreover, rs7635838 in
ATG7 was associated with HDL (p-value = 1.9×10−9). Rs2447607 located in ATG7 showed
association with systolic blood pressure and pulse pressure. Rs2424994 in MAP1LC3A was
associated with coronary artery disease (p-value = 5.8×10−6). Furthermore, we identified
association of an exonic variant located in ATG3 with diastolic blood pressure (p-value =
6.75×10−6). Using DNA methylation data, two CpGs located in ULK1 (p-values = 4.5×10−7
and 1×10−6) and two located in ATG4B (2×10−13 and 1.48×10−7) were significantly associ-
ated with both systolic and diastolic blood pressure. In addition one CpG in ATG4D was
associated with HDL (p-value = 3.21×10−5). Our findings provide support for the role of
autophagy in glucose and lipid metabolism, as well as blood pressure regulation.
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Introduction
Autophagy is a highly conserved catabolic process involved in the degradation of long-lived
proteins and dysfunctional organelles [1]. Under conditions of oxidative stress, hypoxia and
nutrient deprivation, autophagy is activated as a key mechanism of cell survival by degradation
and recycling of damaged organelles and protein aggregates [2]. A disturbance in removal of
these non-functional cellular components is a general impairment in housekeeping of the cell,
and could lead to important phenotypic changes at cell and tissue levels [3]. Several studies,
mainly based on animal models, have provided evidence about the role of autophagy in the
progression of ageing and in particular in atherosclerosis, inflammation, and cardiovascular
disease [2, 4–8]. A number of autophagy-related mechanisms have been studied for cell sur-
vival and in some instances the role of genetic variants involved in molecular mechanisms of
autophagy were investigated in relation to cardiometabolic health in animal models [9]. Sys-
temic knockout of autophagy-related genes (ATG) in mice has shown the role of dysfunctional
autophagy in hyperglycemia [10], hypoinsulinemia and increased basal Ca2+ concentrations
in vascular smooth muscle cells [11, 12]. However, this association has not been studied at
population level. Genetic and epigenetic variations in ATG could affect the autophagy process
in human cells, modify certain metabolic traits and eventually cause susceptibility to cardiome-
tabolic disorders [13, 14]. In this study, by using Genome-Wide Association Studies (GWAS)
data and data from the Rotterdam Study, a population-based prospective cohort study, we
aimed to examine the association of genetic and epigenetic variation in ATG with intermediate
vascular traits and cardiovascular outcomes.
Materials and methods
The Rotterdam Study has been approved by the Medical Ethics Committee of the Erasmus
MC (registration number MEC 02.1015) and by the Dutch Ministry of Health, Welfare and
Sport (Population Screening Act WBO, license number 1071272-159521-PG). The Rotterdam
Study has been entered into the Netherlands National Trial Register (NTR; www.trialregister.
nl) and into the WHO International Clinical Trials Registry Platform (ICTRP; www.who.int/
ictrp/network/primary/en/) under shared catalogue number NTR6831. All participants pro-
vided written informed consent to participate in the study and to have their information
obtained from treating physicians.
Identification of autophagy-related genes
To select the set of autophagy-related genes to be studied, a literature search was performed
and was updated by August 2018 in PubMed using the MeSH terms: Autophagy, genome-
wide association studies, candidate gene studies, and knockout experimental models. We iden-
tified a total of 30 genes related to autophagy and associated pathways. We further included
the genes in the pathway analysis done by QIAGEN’s Ingenuity Pathway Analysis Software
(IPA, http://www.ingenuity.com, Fig 1) to determine genes enriched for autophagy. Core
Analysis implemented by IPA was used to interpret the role of these genes in the context of
biological processes, pathways and molecular networks. IPA uses right-tailed Fisher exact test
to identify enriched canonical pathways and diseases associated to these genes. A p-
value < 0.05 was considered significant. A set of 21 genes showed significant enrichment for
autophagy (p-value = 1.33×10−40) (Table 1). We studied genetic variants within the genes and
those located within 10 MB upstream and downstream of the gene. We excluded SNPs with a
reported minor allele frequency (MAF) less than 1% in NCBI.
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Genetic association
For each gene, we studied the association of the genetic variants intermediate vascular traits
and cardiovascular outcomes. We extracted the summary statistics for the association of the
selected SNPs with traits and diseases from the most recent GWAS meta-analysis of 12 traits:
fasting glucose, fasting insulin, fasting proinsulin [15–18], type 2 diabetes [19], systolic blood
pressure (SBP), diastolic blood pressure (DBP) [20], total cholesterol (TC), triglycerides (TG),
HDL cholesterol (high density lipoprotein), LDL cholesterol (low density lipoprotein) [21]
and coronary artery disease (CAD) [22]. Details of the consortia included are provided in S1
Note and number of subjects included in each study is shown in Table 2.
Exonic variants
We studied the association of exonic variants and DNA methylation status in ATG with lipid,
glycemic and intermediate vascular traits using data from the Rotterdam Study. The Rotter-
dam Study is an ongoing prospective, population-based cohort study started in 1990 including
subjects from Ommoord district in the city of Rotterdam (The Netherlands). The objectives
and details of the study are described elsewhere [24]. The Rotterdam Study comprises a total
of 14,926 subjects aged 45 years and over who were recruited in three sub cohorts in 1989–
1993, 2000–2001, and 2006 [24]. Genomic DNA was extracted from peripheral blood mono-
nuclear cells. Whole-Exome sequencing (WES) was performed at the Rotterdam Genomics
Fig 1. Molecular pathway of autophagy. Autophagy activation is controlled by several factors, including amino acid and nutrient deprivation, which stimulates mTOR-
related pathways. Upon mTOR inhibition by starvation or rapamycin, ATG13/ULK1/FIP200 form a stable complex, essential for autophagy activity. Highly coordinated
autophagy-related proteins are recruited to the phagosphore to participate in the autophagosome formation. ATG7 is one of the crucial regulators of this process.
Lipidation of LC3-I known as LC3-II is attached to the autophagosome membrane and is widely used to monitor autophagy induction. When autophagosome formation is
completed, the fusion between autophagosome and lysosome is mediated by lysosomal membrane protein LAMP-2. ATG12 conjugation to ATG5 is a crucial step in
autophagosome formation. ATG7 regulates ubiquitin-like reaction that mediates this mechanism and subsequent processes in the autophagy machinery.
https://doi.org/10.1371/journal.pone.0214137.g001
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Core in Erasmus Medical Centre. WES was conducted on 2,998 paired-end sequenced samples
using the Illumina hiSeq2000 (2×100bp reads). Indels and single nucleotide variants were fil-
tered out and evaluated using GAKs Variant Evaluation; variants with a call rate<0.97, dupli-
cate samples, duplicate variants and>5% of missing genotypes were considered as exclusion
criteria. A total of 2628 samples passed through all technical quality control and GATKs Hap-
lotype Caller was used to call SNPs and indels simultaneously. Annovar software tool was used
to functionally annotate each genetic variant. Each variant was coded as 0, 1 and 2 representing
two reference alleles, one reference allele and one mutated allele and two mutated alleles,
Table 1. Autophagy-related genes and the number of SNPs selected for this study.
Gene Pathway Chromosome Independent SNPs
AMBRA1 Autophagic vacuole formation 11 34
ATG1 Molecular activation of autophagy 12 18
ATG3 Protein transport. Protein ubiquitination 3 27
ATG4B Autophagic vacuole formation 2 8
ATG4C Autophagic vacuole formation 1 43
ATG4D Autophagic vacuole formation 19 19
ATG5 Autophagic vacuole formation 6 49
ATG7 Protein transport. Protein ubiquitination 3 98
ATG9A Autophagic vacuole formation 2 11
ATG9B Autophagic vacuole formation 7 16
ATG10 Protein transport 5 101
ATG12 Autophagic vacuole formation 5 12
ATG16L1 Autophagic vacuole formation 2 43
ATG16L2 Protein transport 11 8
BECLIN-1 Regulation of autophagy 17 2
DRAM1 Autophago-lysosome formation 12 43
GABARAP Autophagic vacuole formation 17 7
GABARAPL1 Autophagic vacuole formation 12 23
GABARAPL2 Autophagic vacuole formation 16 11
MAP1LC3A Autophagic vacuole formation 20 16
MAP1LC3B Autophagic vacuole formation 16 15
https://doi.org/10.1371/journal.pone.0214137.t001
Table 2. Description of GWAS meta-analysis on cardiometabolic disorders.
Trait Consortium Sample size
Coronary artery disease UK Biobank/CardiogramplusC4D [23] 122,733 cases / 424,528 controls
Fasting glucose MAGIC [15] 133,010
Fasting insulin MAGIC [16] 108,557
Proinsulin MAGIC [17] 10,701
Type 2 diabetes DIAGRAM [19] 26,676 cases / 132,532 controls
Blood pressure UK biobank [20] 140,000
Total cholesterol ENGAGE [21] 100,184
Triglycerides ENGAGE [21] 96,598
HDL cholesterol ENGAGE [21] 99,900
LDL cholesterol ENGAGE [21] 95,454
MAGIC: Meta-analysis of Glucose and Insulin-related traits Consortium; DIAGRAM: Diabetes Genetics Replication and Meta-analysis; CARDIOGRAMplusC4D:
Coronary Artery Disease Genome wide replication and Meta-analysis plus Coronary Artery Disease; HDL: High density lipoprotein; LDL: Low density lipoprotein
https://doi.org/10.1371/journal.pone.0214137.t002
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respectively. Based on the functional annotation, we identified a total of 13 loss of function
(LoF) variants defined as changes in DNA sequence predicted to completely disrupt the forma-
tion and/or function of a protein.
DNA methylation data collection and normalization
DNA was extracted from whole peripheral blood (stored in EDTA tubes) by standardized salt-
ing out methods. The Infinium HumanMethylation450 BeadChip array was employed to
determine the gene methylation status using DNA from whole blood samples of 468 individu-
als from third visit of the second sub-cohort, 731 individuals from first visit of the third sub-
cohort, and 251 individuals from second visit of the third sub-cohort (no-overlap). The array
covers approximately 485,577 methylation sites (in 99% of Ref Seq genes approximately) with
an average of 17.2 CpG sites per gene region. In short, samples (500 ng of DNA per sample)
were first bisulfite treated using the Zymo EZ-96 DNA-methylation kit (Zymo Research,
Irvine, CA, USA). Next, they were hybridized to the arrays according to the manufacturer’s
protocol. The methylation percentage of a CpG site was reported as a beta-value ranging
between 0 (no methylation) and 1 (full methylation). The quality control of DNA methylation
data was conducted for both sample and probe based on a p-value threshold for gene detection
of 0.01. Data normalization was done based on color bias correction of methylated and
unmethylated signals, per plate and separate color background adjustment. Outliers beyond
the 3rd quartile were excluded and the final dataset comprised 463,456 CpG sites.
Clinical traits and outcomes
Lipid measurements were carried out using venous blood samples obtained from all partici-
pants of the Rotterdam Study. Total cholesterol, high-density lipoprotein cholesterol, and tri-
glycerides were measured on the COBAS 8000 Modular Analyzer (Roche Diagnostics GmbH).
Low density lipoprotein cholesterol levels were estimated indirectly from measurements of
TC, HDL, and TG by means of the Friedewald equation [25]. The corresponding interassay
coefficients of variation was <2.1%.
During each visit, blood pressure was measured twice in the right arm using a random-zero
sphygmomanometer, in sitting position, after a resting period of 5 minutes. After 2006 Omron
M6 Comfort and Omron M7 devices were used. The measurements were taken in duplicate. The
average of the 2 measurements was used in the analyses. A qualified physician at the research
center collected data on indication for use of BP-lowering medication during the interview.
Glucose and insulin were measured from venous blood samples. Fasting insulin and glu-
cose were measured on the COBAS 8000 Modular Analyzer (Roche Diagnostics GmbH). The
interassay coefficients of variations are <8% and<1.4% for insulin and glucose respectively.
Type 2 diabetes was defined according to recent WHO guidelines, as a fasting blood
glucose� 7.0 mmol/L, a non-fasting blood glucose� 11.1 mmol/L (when fasting samples
were absent), or the use of blood glucose lowering medication [26]. Information regarding the
use of diabetes medication was collected from both structured home interviews and linkage to
pharmacy records [27].
Statistical analysis
SNP pruning and Genome-wide association studies look up. We found 5398 SNPs in
the 21 identified autophagy genes. Linkage disequilibrium (LD)-based SNP pruning imple-
mented in PLINK software was applied using a genetic correlation threshold of 0.5 to calculate
the number of independent SNP per gene [28]. Using LD pruning, we identified 604 indepen-
dent SNPs in 21 genes directly involved in autophagy pathway. We applied Bonferroni
Association between autophagy and cardiometabolic disorders: The Rotterdam Study
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correction for 604 SNPs and 4 traits. The study-wide significance threshold was set at
2.07×10−5 (0.05/604 SNPs×4 traits).
Exome sequencing. We used Seqmeta, an R package to perform region-based tests of rare
DNA variants, to conduct multiple regression models in order to determine association
between LoF variants and intermediate vascular traits including age and sex as a covariates.
The package allows to obtain the scores and MAF for each gene with the function prepScores
and to calculate both gene-based and single variant-based associations based on the prepScores
output [29, 30]. The significance level was based on Bonferroni correction to adjust for multi-
ple comparisons according to the number of variants and traits being tested. Here, we set a p-
value threshold as 9.62×10−4 (0.05/(4 traits×13 LoF))
Epigenome-wide association studies. We conducted epigenome wide association studies
(EWAs) on blood pressure, glucose, insulin, HDL, LDL, triglycerides and total cholesterol.
Beta-values to quantify the DNA methylation levels were used in a linear mixed-effect regres-
sion model with the outcomes of interest as a dependent variable. We fit the primary regres-
sion model adjusting by age and sex, cell counts, technical covariates and smoking. Further
adjustments including, hypertensive or lipid lowering treatment, prevalent diabetes mellitus
were employed for blood pressure and lipids levels respectively. We combined the results of
the three sub-cohorts by conducting a fixed effect meta-analysis using the inverse variance
method implemented in METAL [31]. We established the target set of ATG-CpGs considering
the CpG islands found in upstream, downstream and promoter regions of each gene. CpG
sites per gene were obtained using the UCSC genome browser (http://genome.ucsc.edu/). Sta-
tistically significant association was set at 5.63×10−5 based on Bonferroni correction for 296
CpG sites and three trait groups (glycemic traits, lipids and blood pressure). Next to the identi-
fication of epigenetic marks in ATG genes, we extended our search of methylation quantitative
trait loci (meQTLs) by the identification of both cis and trans associated SNPs using a large
meQTLs dataset from mQTLdb resource (http://www.mqtldb.org/) [32].
Results
Genetic association
The results of genetic association of the SNPs and cardiometabolic traits are presented in S1
Table. The lead significant variants are presented at Table 3. Six SNPs at three genes, AMBRA1
(Lead SNP: rs11038913), ATG13 (rs8914), and ATG16L1 (rs4944804) passed the significant
threshold for association with pro-insulin serum levels. Total cholesterol level was significantly
associated with 34 SNPs at ATG4D (rs10439163) and one SNP at ATG4C (rs6587988). HDL-
cholesterol was associated with 41 variants at ATG7 (rs7635838). One SNP at ATG4D
(rs10439163) was associated with LDL-cholesterol and the one at ATG4C (rs6587988) was fur-
ther associated with triglyceride levels. Moreover, 56 SNPs and 38 SNPs located in ATG7 were
associated with SBP and pulse pressure, respectively. Two SNPs (rs2424994 and rs6088521)
located at MAP1LC3A showed an association with CAD.
In addition to this significant association, we also observed borderline significant associa-
tion between SNPs at ATG7 with SBP, ATG4B with fasting proinsulin, and MAP1LC3A with
HDL-cholesterol. No associations were found between ATG and type 2 diabetes.
Loss of function variants
We used data from 2,628 participants of the first sub-cohort of the Rotterdam Study. Baseline
characteristics of the individuals are presented in S2 Table. We identified 13 LoF stop-gain or
splicing mutations in ATG4C, ULK1, GABARAPL2, GABARAP, ATG4D, ATG3, ATG10 and
ATG5 (Table 4). We used single variant-based analysis implemented in SeqMeta to assess the
Association between autophagy and cardiometabolic disorders: The Rotterdam Study
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association of LoF mutations with intermediate vascular traits. We identified one exonic vari-
ant in ATG3 associated with DBP and fasting glucose (p-value for SBP: 0.054). The C/A variant
found in this gene is considered a nonsense mutation and is related with stop-gain function of
the protein. We also found a nominally significant association between an exonic variant in
ULK1 and triglycerides (p-value = 0.0012). The results of association between these variants
and studied traits and diseases are mentioned in S3 Table.
DNA methylation at autophagy genes
In total, 1450 individuals with a mean±SD age of 60.6 ± 5.3 years were included in the analysis.
The association of the studied CpGs and all traits and diseases are presented in S4 Table. In a
fully adjusted model, we found differential methylation at ATG4B and ULK1 were associated
with blood pressure (Table 5). Hypermethylation in these CpGs were associated with lower
SBP/DBP. On the other hand, no significant associations between DNA methylation and gly-
cemic and lipid traits were found in the study population. Using mQTLdb database, we identi-
fied five trans-meQTLs associated with cg02710553. The variants were located in an intergenic
region close to MAP3K7. Furthermore, 23 trans-meQTLs associated cg06006530 were identi-
fied close to CDH18 gene. meQTLs of cg02710553 were found to be associated with CAD at
nominal significance level (p-value = 0.02).
Table 3. SNPs in autophagy genes with the most significant association with cardiometabolic traits and diseases.
SNP Gene Trait/Disease P-value MAF
rs7635838 ATG7 HDL-cholesterol 1.9×10−9 0.49
rs2447607 Systolic blood pressure 3.2×10−8 0.40
Pulse pressure 3.5×10−7 0.40
rs10439163 ATG4D LDL-cholesterol 9.9×10−12 0.43
Total cholesterol 1.4×10−10 0.43
rs7255312 Coronary artery disease 6.1×10−6 0.10
rs6587988 ATG4C Triglycerides 3.1×10−18 0.24
Total cholesterol 2.5×10−15 0.24
rs11038913 AMBRA1 Fasting proinsulin 4.9×10−18 0.08
rs8914 ATG13 7.1×10−18 0.03
rs4944804 ATG16L1 8.9×10−18 0.13
rs6088521 MAP1LC3A Coronary artery disease 4.1×10−6 0.50
MAF: minor allele frequency; HDL: High-density lipoprotein; LDL: low-density lipoprotein. Significance threshold: 2.07×10−5
https://doi.org/10.1371/journal.pone.0214137.t003
Table 4. LOF variants associated with intermediate vascular traits.
Variant Gene Trait P-value
3:112277264 ATG3 Diastolic blood pressure 6.8×10−6
Fasting glucose 0.043
12:132404136 ULK1 Triglyceride 1.3 ×10−3
12:132404136 ULK1 Total cholesterol 0.18
12:132404136 ULK1 HDL-cholesterol 0.08
12:132404136 ULK1 Fasting insulin 0.65
12:132404136 ULK1 LDL-cholesterol 0.19
12:132404136 ULK1 Systolic blood pressure 0.05
Significance threshold: 9.61×10−4
https://doi.org/10.1371/journal.pone.0214137.t004
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Discussion
In this study we used genetic and epi-genetic factors to assess the role of autophagy genes in
cardiometabolic traits and disorders at population level. To this end, we utilized a number of
genetic variants, LoF variants and DNA methylation in autophagy related genes. All
approaches indicated associations between autophagy genes and certain cardiometabolic traits,
mainly blood pressure, lipid levels and proinsulin levels but not coronary artery disease.
Our findings on the association between genetic variants in AMBRA1, ATG13 and ATG16L1
and proinsulin levels are in agreement with previous evidence reporting autophagy deficiency as
an important determinant in the pathogenesis of insulin resistance and diabetes [33]. AMBRA1
participates in the activation of beclin-1-regulated autophagy and favors the autophagosome
core complex with the participation of other ATG proteins such as ATG13 and ATG16L1 [34].
The upstream autophagy-signaling network controlled by AMBRA1 is crucial for the metabolic
response to a vast number of stress stimuli, ranging from starvation to hypoxia or DNA damage.
Dysfunctional autophagy has been suggested as a key process related to an impaired proinsulin/
insulin homeostasis observed in pancreatic beta cells from experimental models [35]. Condi-
tional knockout of ATG7 in high-fat-fed C57BL/6 mice has resulted in declined insulin secre-
tion, impaired glucose tolerance and degeneration of pancreatic islets [36]. In autophagy-
deficient cells, the insulin secretion is restrained enabling the proinsulin accumulation in secre-
tory granules and increased secretion in response to stimuli [37]. At population level, in line
with our findings, an exome array analysis conducted in 8229 individuals showed association
between genetic variants in AMBRA1 and ATG13 with fasting proinsulin concentrations [38].
The role of impaired autophagy in proinsulin degradation has highlighted the importance of the
autophagy pathway on the design of novel therapeutic strategies, aimed to manipulate proinsulin
clearance as means to increase the insulin secretion in diabetic population.
Our findings on common genetic variants in ATG and blood lipids support the hypothesis
that autophagy may play a role in dyslipidemia. The role of impaired autophagy and lipid
metabolism has been established from the identification of significant increased levels of
hepatic triglycerides and cholesterol content in hepatocyte-specific knockout mice of ATG5
[39]. Moreover ATG7 knockout mice models have displayed severe morphological abnormali-
ties in the structure of white adipocytes, as well as an aggravated insulin resistance with
increased lipid content and inflammatory changes [40, 41]. In summary, upregulation of
autophagy leads to a decrease of triglycerides and cholesterol in plasma, reduced lipid store as
well as LDL oxidation and free fatty acid B-oxidation and an increase of folding and traffic
proteins [42]. Further investigations are needed to clarify this association and potential path-
ways linking autophagy with blood lipids levels. Recent findings of a critical role for macroau-
tophagy in the metabolism and storage of cellular lipids have now suggested that alterations in
autophagy may mediate human disorders marked by excessive cellular lipid stores.
Table 5. DNA methylation, blood pressure and HDL.
CpG site Gene Trait Effect P-value�
cg08462942 ATG4B Systolic blood pressure -0.00026 2.0×10−13
cg06006530 -0.0019 1.5×10−7
cg02710553 ULK1 Systolic blood pressure -0.0018 4.5×10−7
Diastolic blood pressure -0.0018 1.0×10−6
cg10819350 ATG4D HDL-cholesterol -0.0158 3.2×10−5
�Adjusted for age, sex, cell counts, batch effects, anti-hypertensive and lipid-lowering medication
HDL: high density lipoprotein, significance threshold: 5.63×10−5
https://doi.org/10.1371/journal.pone.0214137.t005
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In contrast, mice with endothelial specific deletion of ATG7 have shown normal blood pres-
sure and normal vessel architecture compared to wild types [43]. We further identified a sug-
gestive association between LoF variants annotated in ATG3 and glucose levels. It has been
shown that glycogen autophagy in newborns serves as a mechanism of glucose homeostasis
[44]. In adult animals, the administration of glycogen autophagy-inhibiting insulin triggers a
reduced rate of breakdown of liver glycogen by autophagy [45]. Impaired mechanisms related
to autophagosomal glucose production and the influence of gluconeogenesis may lead to a dis-
sociation of gluconeogenic glucose production from blood glucose levels [46]. On the other
hand, we found no association between changes in DNA methylation patterns and glycemic
traits. This might be explained by the fact that methylation is a tissue-specific process. There-
fore, SNPs could be operating independently from methylation patterns.
We studied DNA methylation at autophagy-related genes and found differential patterns at
ULK1 and ATG4B associated with blood pressure levels. Increased blood pressure is deter-
mined by a complex machinery regulated, among others, by the renin-angiotensin system
(RAS) [47]. The interaction between autophagy and RAS has been previously examined. Por-
rello et al, provided the first evidence for an interplay between these two mechanisms in cardi-
omyocytes. This study reported that rat cardiomyocytes developed and augmented (via the
angiotensin II receptor type 1) or inhibited (via the angiotensin II receptor type 2) autophagic
response on stimulation by angiotensin II [48]. The association between autophagy and blood
pressure found in our study could be explained by its interaction with RAS and its role in
hypertension. Given the fact that autophagy and RAS are both involved in many pathophysio-
logical processes, further investigation is warranted to better understand the molecular mecha-
nism behind this interaction and its role in pathological conditions. In addition, we found an
association between DNA methylation in ATG4D and HDL levels. ATG4D is known to partici-
pate in the delipidation of GABARAP-L1, whereas the silencing of ATG4D abrogates GABAR-
AP-L1 autophagosome formation [49]. Experimental evidence of the role of this gene on lipid
transport/metabolism is currently lacking.
Epi-genetic associations are subject to confounding and reverse causation. One approach to
overcome these biases in molecular epidemiology is to use genetic instruments. In this study,
we found that meQTL at cg02710553 was associated with CAD. This might indicate that the
association of cg2710553 and CAD is causal.
We used both genomics and epi-genomics data to examine the role of autophagy related
genes in cardiometabolic traits and diseases. Although we have several significant association,
we did not find a consistent association with a certain gene or a certain trait across all
approaches. It should be noted that genomic and epi-genomic approaches are not always
pointing to the same gene. Moreover, it is not a surprise if a different gene in a certain pathway
has more or less importance for a certain trait. The high complexity of the autophagy mecha-
nism may be a major contributor of the heterogeneity of the findings in our results [50].
Our study has several strengths. First, we used data from largest GWAS, which has provided
the best statistical power that could be achieved. Second, we used both genetic and epi-genetic
approaches towards the research question. Third, we used exome sequence data, which in con-
trast to GWAS, is not based on a studying a proxy variant. Our study also had several limita-
tions. First, the sample size for exome sequence analysis was much smaller than the GWAS,
thus the statistical power was significantly lower. Loss of function variants are mostly found in
low frequency, indicating that they are enriched for mildly deleterious polymorphisms sup-
pressed by negative natural selection [51]. Therefore, smaller populations might also provide
enough statistical power to detect their effect, however, this could not be ruled out that lack of
association in our analysis might be a results of small sample size.
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Second, DNA methylation pattern is tissue/cell line specific. As it is common in epidemio-
logic studies we used DNA methylation in whole blood, a cell type mixture, which might not
be relevant for some of the traits. In our study DNA methylation was captured from the assess-
ment of leukocytes. Although leukocytes are not relevant tissue for some of the traits that we
have assessed in our analysis, they are the main tissue available in large scale in epidemiologic
studies and evidence has demonstrated that methylation patterns might correlate between
blood and the relevant tissues, suggesting that the use of blood tissue could yet be informative
[52–55]. However, such findings should be validated in subsequent studies.
In conclusion, this study is the first to examine the role of autophagy-related genes in inter-
mediate vascular traits using a population-based approach. We have characterized the role of
common and rare genetic variants as well as epigenetic variations of autophagy-related genes
on several traits. Despite the heterogeneity of our findings across approaches employed and
traits evaluated, we found many associations between autophagy genes and cardiometabolic
traits and diseases. The integral approach covered by this study could contribute to further
analysis evaluating the role of autophagy in other human diseases and traits, as well as the
design of experimental studies targeting other autophagy-related genes and/or associated
pathways.
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